Centricity Research

Toronto, Ontario M9W 4L6

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer Disease, Influenza, Mild Cognitive Impairment, Mild Dementia, SARS-CoV-2, Type 1 Diabetes Mellitus

Studies at this site

• Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus — Stopped early
• A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine) — Completed
• Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test — Completed